Skip to content

Intraoperative Methadone in Children Undergoing Surgery

The Use of Intraoperative Methadone in Children Undergoing Open Urological Surgery: a Randomized, Double-blind Trial

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04680286
Acronym
METACEBO
Enrollment
60
Registered
2020-12-22
Start date
2020-11-16
Completion date
2024-02-01
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Acute, Pain, Postoperative, Children, Only

Keywords

methadone, analgesics, opioids, postoperative, placebo

Brief summary

A prospective double-blind, randomized controlled trial investigating the effect of a single-dose of intraoperative methadone on postoperative pain and opioid consumption in 96 children undergoing open urological surgery.

Detailed description

Treatment of postoperative pain is a challenge in younger children undergoing outpatient surgery. After discharge parents must assess pain intensity and administer analgesics, including opioids, as per needed. It has been shown that parents often hesitate to administer analgesics. The result is unrelieved pain that negatively affects the whole family and increases the risk of unscheduled contacts with healthcare professionals. In children, methadone has shown a half-life of 19,2 +/-13,6 hours. Regarding outpatient surgery, methadone is an opioid with unique pharmalogical properties that may be advantageous. A single-dose of this long acting opioid administered perioperatively could provide a stable analgesia and potentially reduce the need for shorter-acting opioids in the PACU and at home.

Interventions

Single dose, intravenous bolus, 0,1 mg/kg administered at induction of anesthesia.

OTHERPlacebo

Single dose, intravenous bolus. Administered as the experimental arm.

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Randomisation and study medication will be handled by the hospital pharmacy. All research team members, caregiving clinicians and enrolled patients will be blinded to the study allocation arms and the randomisation list will be concealed until all statistical analyses are made.

Intervention model description

Randomized controlled trial.

Eligibility

Sex/Gender
MALE
Age
0 Years to 4 Years
Healthy volunteers
No

Inclusion criteria

Children scheduled for open urological surgery at the Outpatient Clinic at Aarhus University Hospital.

Exclusion criteria

* Age =/\> 5 years at the date of operation * Born preterm (Before gestational age of 37 weeks) * Congenital heart disease * Previous scrotal surgery * Laparoscopic operation * American Society of Anaesthesiologists (ASA) physical status lll, IV or V * Allergy to study drugs * Preoperative daily use of opioids * Parents with inability to provide informed consent * Severe respiratory insufficiency * Acute abdominal pain * Severe kidney insufficiency * Treatment with rifampicin

Design outcomes

Primary

MeasureTime frameDescription
Pain intensity (highest score)3 hoursFLACC-score - Face, Legs, Activity, Cry og Consolability, 0-10, where 10 is the highest pain score. Within the first 3 hours from extubation (or until discharge from PACU, if discharged before 3 hours)
Patients consumption of analgesics in the PACU.3 hoursWithin the first 3 hours from extubation (or until discharge from PACU, if discharged before 3 hours).

Secondary

MeasureTime frameDescription
Patients need of supplemental oxygen in PACU3 hoursNeed of supplemental oxygen within the first 3 hours after extubation,(or until discharge from PACU, if discharged before 3 hours)
Awakenings during the first night after discharge.24 hoursParents will answer whether the child have been awake and whether they believe the awakening(s) where due to pain.
Analgesic consumption following discharge until evening on the first postoperative day36 hoursFrom discharge until 8 PM the first day following surgery. Collected by parents.
Unscheduled parental contacts to the hospital4 daysParental contacts to hospital regarding pain and/or analgesics until 4 days following surgery.
Pain intensity the first postoperative day48 hoursAssessed by parents, 3 FLACC-scores - Face, Legs, Activity, Cry og Consolability, 0-10, where 10 is the highest pain score, during the first postoperative day.
Readiness to discharge6 hoursTime for readiness to discharge from PACU assessed by PACU nurse.

Other

MeasureTime frameDescription
FLACC-scores - Face, Legs, Activity, Cry og Consolability, 0-10, where 10 is the highest pain score, at home48 hoursParental experience with assessment of the FLACC-score at home following discharge.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026